U.S., April 1 -- ClinicalTrials.gov registry received information related to the study (NCT07502755) titled 'Non-invasive Tests for Non-alcoholic Steato-hepatitis' on July 18, 2024.
Brief Summary: The main objective is to study and validate a new approach for NASH and liver fibrosis diagnosis and personalized follow-up based on monocyte biomarkers and plasma metabolites. The investigators will assess if PLIN2 and RAB14 can be used not only to identify subjects with NASH and advanced fibrosis but also for monitoring the effect of treatment alone or in combination with other metabolic parameters
Study Start Date: Aug. 31, 2024
Study Type: INTERVENTIONAL
Condition:
NASH With Fibrosis
Diabete Type 2
Obesity
Intervention:
PROCEDURE: Admin...